Management of Type 2 Gastric Ulcers in Older Adults

Immediate Management Steps

The American College of Gastroenterology recommends immediately discontinuing all NSAIDs and initiating a proton pump inhibitor (PPI) at standard dosing, and testing for H. pylori with subsequent eradication therapy if positive, for an older adult with a Type 2 gastric ulcer 1, 2, 3
Stop all NSAIDs immediately as they significantly increase the risk of ulcer recurrence and complications, even with concurrent PPI therapy, and substitute with acetaminophen for pain relief, which does not cause gastric injury 4
If NSAIDs are absolutely necessary, use a COX-2 selective inhibitor (celecoxib) combined with a PPI for gastroprotection, as recommended by the American Gastroenterological Association 2, 5, 6

Test all patients with gastric ulcers for H. pylori infection using either urea breath test or stool antigen test, as recommended by the American College of Gastroenterology 3
H. pylori infection increases the risk of NSAID-related complications by 2-4 fold, according to the European Helicobacter Study Group 1, 2, 4
Eradication therapy with a triple therapy regimen (PPI + amoxicillin + clarithromycin) for 14 days is recommended for H. pylori-positive patients, as suggested by the American Gastroenterological Association 3
H. pylori eradication reduces the likelihood of peptic ulcers by one-half in NSAID users, and eradication before starting NSAIDs reduces subsequent ulcer risk, according to the National Institute of Diabetes and Digestive and Kidney Diseases 7, 8

Older adults are at particularly high risk for NSAID-associated adverse events, which increase in frequency and severity with age, according to the American Geriatrics Society 9
The American Heart Association recommends avoiding COX-2 inhibitors in patients where cardiovascular risk exceeds gastrointestinal bleeding risk, due to increased cardiovascular risk 5
The combination of COX-2 inhibitor and PPI provides superior protection compared to either agent alone, as recommended by the American College of Gastroenterology 6

H2-receptor antagonists are inadequate for NSAID-associated gastric ulcers, as they only protect against duodenal ulcers, not gastric ulcers, according to the American Gastroenterological Association 3
Poor compliance with gastroprotective agents increases the risk of NSAID-induced adverse events 4-6 fold, as reported by the Clinical Gastroenterology and Hepatology journal 5, 4
Among patients already on long-term NSAIDs, H. pylori eradication is less effective for preventing NSAID ulcers compared to NSAID-naïve patients, according to the Alimentary Pharmacology and Therapeutics journal 7, 8